United Orthopedic (TWO:4129) — Market Cap & Net Worth
Market Cap & Net Worth: United Orthopedic (4129)
United Orthopedic (TWO:4129) has a market capitalization of $250.05 Million (NT$7.94 Billion) as of September 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #15750 globally and #712 in its home market, demonstrating a -0.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying United Orthopedic's stock price NT$82.30 by its total outstanding shares 96438000 (96.44 Million). Also see United Orthopedic assets under control for a full breakdown of the balance sheet.
United Orthopedic Market Cap History: 2015 to 2026
United Orthopedic's market capitalization history from 2015 to 2026. Data shows growth from $161.75 Million to $250.05 Million (5.42% CAGR). Also see how efficiently does United Orthopedic generate cash for how efficiently the company converts equity into cash flow.
United Orthopedic Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how United Orthopedic's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 4129 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
United Orthopedic's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.60x
United Orthopedic's market cap is 0.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $145.38 Million | $1.42 Billion | $146.60 Million | 0.10x | 0.99x |
| 2017 | $161.71 Million | $1.97 Billion | $130.26 Million | 0.08x | 1.24x |
| 2018 | $115.72 Million | $2.32 Billion | $127.55 Million | 0.05x | 0.91x |
| 2019 | $119.41 Million | $2.45 Billion | $88.58 Million | 0.05x | 1.35x |
| 2020 | $101.90 Million | $2.35 Billion | $101.83 Million | 0.04x | 1.00x |
| 2021 | $89.18 Million | $2.57 Billion | $52.27 Million | 0.03x | 1.71x |
| 2022 | $135.33 Million | $3.16 Billion | $221.53 Million | 0.04x | 0.61x |
| 2023 | $248.42 Million | $3.94 Billion | $384.20 Million | 0.06x | 0.65x |
| 2024 | $280.74 Million | $4.65 Billion | $456.43 Million | 0.06x | 0.62x |
| 2025 | $340.29 Million | $5.66 Billion | $562.50 Million | 0.06x | 0.60x |
Competitor Companies of 4129 by Market Capitalization
Companies near United Orthopedic in the global market cap rankings as of September 18, 2026. Review 4129 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to United Orthopedic by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
United Orthopedic Historical Marketcap From 2015 to 2026
Between 2015 and today, United Orthopedic's market cap moved from $161.75 Million to $ 250.05 Million, with a yearly change of 5.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$250.05 Million | -26.52% |
| 2025 | NT$340.29 Million | +21.21% |
| 2024 | NT$280.74 Million | +13.01% |
| 2023 | NT$248.42 Million | +83.56% |
| 2022 | NT$135.33 Million | +51.75% |
| 2021 | NT$89.18 Million | -12.48% |
| 2020 | NT$101.90 Million | -14.67% |
| 2019 | NT$119.41 Million | +3.19% |
| 2018 | NT$115.72 Million | -28.44% |
| 2017 | NT$161.71 Million | +11.23% |
| 2016 | NT$145.38 Million | -10.12% |
| 2015 | NT$161.75 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of United Orthopedic was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $250.05 Million USD |
| MoneyControl | $250.05 Million USD |
| MarketWatch | $250.05 Million USD |
| marketcap.company | $250.05 Million USD |
| Reuters | $250.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more